Skip to Content
MayoACCESS
MayoLINK
Register
My Dashboard
Test Catalog
Algorithms
Download Test Catalog & Interpretive Handbook
New Tests
NY State Informed Consent Tests
Performing Locations
Referred Tests
Specialty Testing
Test Updates
Ordering & Results
Critical Values & Results
Custom Gene Ordering
Forms
LIS Resources
MayoACCESS Resources
MayoLINK Resources
Order Your First Test
Patient Information and Signature Forms
Request Additional Testing
Send Additional Specimen
Specimen Handling
Collection & Preparation
Dangerous Goods Training
Shipping & Courier Guides
Shipping Regulations
Supplies
Customer Service
Billing
Contact Us
FAQ
IT Updates
Joint Test Catalog Admin Resources
Operational Updates
Quality & Compliance
Education & Insights
Educational Resources
News
Outreach
Podcasts
Stories
Contact
Log Out
Return to Answers From the Lab
Assay stratifies pregnant women’s preeclampsia risk: Joshua Bornhorst, Ph.D.
By
Samantha Rossi
•
January 30, 2024
Share this:
Related Episodes
Breakthroughs and Trends That Defined Lab Medicine in 2025
By
Sarah Jarvis
•
December 18, 2025
Accelerating Research and Development With BioPharma Diagnostics
By
Sarah Jarvis
•
December 4, 2025
Unlocking the Unknown With Metagenomics
By
Sarah Jarvis
•
November 20, 2025
Samantha Rossi
Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.
Related Posts
5 Transformations Mayo Clinic Laboratories Advanced in 2025
Laboratory acronyms: What they mean and why they are important
Breakthroughs and Trends That Defined Lab Medicine in 2025
